27
May

08:00 AM PDT

CLINICAL OPERATIONS & ONCOLOGY

Strategy Meeting Online West Coast 2021

Determining Best Practice and Future Outlook in Clinical Operations and Oncology post Covid-19

Strategy Meetings

Insights without leaving your home

Looking for a unique online conference experience? Want a chance for real discussions and genuine networking? Proventa International’s online Clinical Operations and Oncology strategy meetings help you make those important connections through interactive roundtable discussions and keynote panel debates – all in a totally online format.

Join clinical operations & oncology professionals from across the West Coast. Engage with your senior peers, discover new insights and help take your company to the next level.

What makes our strategy meetings unique?

Roundtable Discussions

Intimate discussions led by renowned clinical and oncology experts. Have your voice heard and debate alongside like-minded life science executives.

Unrivalled Networking

With senior delegation from big pharma and innovative biotech from across the West Coast, you can network with peers from different locations, all in one place.

Personalised Agenda

Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.

Totally Virtual Format

It’s more important than ever to encourage collaboration while promoting safety and accessibility. And that’s exactly what you can expect from our online meeting format.

Industry Researched Topics

We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.

Senior Decision Makers

The entire Strategy Meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are perfecting their clinical operations and dealing with the same challenges as you.

Facilitator Faculty

Each interactive roundtable is led by one of our expert facilitators. Take a look who you could be joining online.

Andreas Bader

Senior Vice President of R&D Triumvira Immunologics

Ash Rishi

CEO and Co-founder, Founder COUCH Health, Demand Diversity and COUCH Academy

Reid Bissonnette

Vice President, Immuno-Oncology TargaZyme, Inc.

Gajanan Bhat

Vice President, Clinical Science/Biostatistics Spectrum Pharmaceuticals

Veronica Cuevas Brenner

Vice President Quality and Regulatory Eselle Health

Elena Brin

CSO & CEO Athae Bio

Michael A. Damore

Head Translational Oncology Lead Pfizer

Tatiana Eidus

Director Corporate Development North America, USA Arensia

Celeste A. Elash

Vice President, eCOA Science YPrime

Erin Filbert

Associate Director – Immuno-Oncology Research Apexigen

Erin Finot

Global Head, Immuno-Oncology IQVIA Biotech

The Global Head of Immuno-Oncology at IQVIA Biotech, Erin is responsible for leading the team’s 
strategic direction to help sponsors focused on immuno-oncology trial programs meet their goals with 
high quality and delivery of our innovative services and solutions and expertise. 
As advancements in immuno-oncology continue to transform cancer care, Erin is able to successfully 
guide sponsors through a dynamic landscape with strong therapeutic expertise and more than 18 years 
of experience in global clinical research and drug development processes, including adoptive cellular 
trials. 
Erin’s educational background, including a bachelor’s degree in Biology from the University of California, 
Berkeley and a master’s degree in immunology from the University of Virginia, provides a solid 
foundation for her therapeutic expertise. She has also earned a Master of Business Administration in 
Finance and Accounting from the University of Louisiana, Shreveport.

Rachel Gaskell

Senior Director Clinical Development GSK

Majid Ghoddusi

Executive Director, Clinical Biomarker Poseida Therapeutics

Ari Gnanasakthy

Principal Scientist RTI Health Solutions

Claudia Hesselmann, PhD

Co-founder & CEO ARENSIA

Jack Hiro

CEO Regenica Biosciences

Niharika Kamat

Director of Clinical Operations Catalyst Biosciences

Tahira Khan

Senior Director, Regulatory Affairs Nektar Therapeutics

Andy Kinley

Global Head, Oncology Strategy IQVIA Biotech

Tanya Russell Kirkpatrick

VP Clinical Operations Head – Oncology, Global Product Development Pfizer

Elina Lavit

Vice President of Business Development OncoNano Medicine

John Makowski

Executive Director, Clinical Operations Audentes Therapeutics

Prasun Mishra

CEO, Founder / CEO, Founding President r, Agility Pharmaceuticals / American Association for Precision Medicine (AAPM)

Donna M. Mongiello

Vice President, Strategic Solutions YPrime

Donna M. Mongiello, RN, BSN.  Based in the Northeastern US, Donna’s diverse career began in 
healthcare as a registered nurse and over the last several decades evolved into technologies that 
support patients in clinical research.  Donna has published articles in trade journals and presented at 
pharmaceutical industry conferences on topics including patient centricity, improving enrollment 
success, eCOA, and BYOD.  Donna’s nursing background and subsequent work supporting sponsors has 
left her with a strong desire to improve clinical research from the patient’s perspective, simplify study 
conduct, and make study participation less burdensome for patients. Donna is excited to be a part of 
this ever changing healthcare technology arena and looks forward to the continued ways technology can 
improve the patient’s experience.  Donna earned her bachelor of science degree in nursing from Thomas 
Jefferson University, and studied electrical engineering and psychology at Drexel University.

Ralph Passarella

CEO and Co-Founder Reify Health

Ralph Passarella is the CEO and Co-Founder of Reify Health, where he and his team are working to accelerate the development of new, life-saving therapies. Reify’s technology connects the workflows of biopharmaceutical companies and clinical trial sites around the globe to streamline their work together and cut down the time it takes to complete trials. Thousands of research sites and many of the largest biopharma companies in over 50 countries rely on Reify Health’s products to enroll their clinical trials effectively and conduct high quality research.
Through their work at Reify, Ralph and team also co-founded Signal Vine, an education technology company helping students navigate the administrative parts of higher education. Signal Vine works with hundreds of colleges and college access organizations to help millions of students around the US matriculate to college and persist through for their degree. Ralph currently serves on the Signal Vine Board of Directors.
Prior to starting Reify Health, Ralph graduated from Vanderbilt University with a BA in Molecular and Cellular Biology and completed the first two years of the MD/PhD program at Johns Hopkins University School of Medicine.
Before putting his studies on pause, Ralph’s work as an entrepreneur and researcher was recognized nationally by the National Cancer Institute, the American Medical Informatics Association, and the Clinical Global Initiative. His undergraduate work in radiation-guided chemotherapeutic drug delivery was recognized as the Most Outstanding Undergraduate Research in the nation by the American Association for Cancer Research as well.

Jonathan Rabinowitz

Professor Bar-Ilan University

Jonathan Rabinowitz is an Elie Wiesel Professor at Bar Ilan University and a visiting professor at Mount Sinai School of Medicine in New York. He is the Founder and Director of DupCheck, and his research focuses on improving safety and efficiency of clinical trials. Jonathan is the academic lead of the Advanced Data Analysis Techniques group at European Union Innovative Medicines Initiative funded NEMWEDS, one of the largest ever collaboration projects directed at finding safer and more efficient drug development methods. Jonathan did his Doctoral training in Statistics at Bar Ilan University and in Social Welfare at Yeshiva University, and serves on advisory groups at FDA and EMA. He is a member of the American College of Neuropsychopharmacology, and is on the Executive Committee of International Society for CNS Clinical Trials and Methodology, and serves as co-chair of the working group on consistency in measurement. He has over 170 scientific publications.

Ash Rishi

CEO and Co-founder, Founder COUCH Health, Demand Diversity and COUCH Academy

Kevin Ryan

VP and Chief Compliance Officer ACADIA

Archana Sah

Vice President, Head of Clinical Development Operations Tizona Therapeutics, Inc

Archana Sah serves as Tizona’s Vice President and Head of Clinical Operations and is responsible for overall strategic direction, growth and leadership of Tizona’s Clinical Operations team and the delivery of the clinical trial portfolio. Archana brings over 25 years global experience from pharma, biotech and CRO industries developing medicines for patients having led and contributed to 15 FDA/EMEA drug approvals in Oncology, Immuno-Oncology, Precision 
Therapeutics, Rare Diseases, Metabolic Diseases and Women’s Health. She has held various global positions within Biotech, Big pharma and Oncology startup companies. Prior to Tizona, she was the Therapeutic Area Leader for Oncology at Genentech, a member of the Roche Group where she led Clinical Operations and was accountable for operational strategy and execution of the oncology clinical trial portfolio from early development to late stage development. She also provides advisory services for organizations developing and implementing innovative approaches for clinical research and medicine/medtech development. Ms. Sah was the founding co-Chair of the Society for Clinical Research Sites (SCRS) Oncology Board for three years (2018-2020) to lead cross industry collaboration in Oncology Drug Development setting the vision, mission and overseeing the strategy of the SCRS Oncology Program. She has chaired the Annual Oncology Site Solutions Summit focused on delivering best practices and solutions for operational excellence in Oncology Clinical development and operations across the entire ecosystem.
Ms. Sah also serves as an advisor for American Cancer Society Cancer Action Network and was a past advisor for Forum on Drug Discovery &amp; Development for National Academy of Sciences on Clinical Trial Site Standards and Harmonization.
Ms. Sah received her Master’s in Pharmaceutical Sciences from University of Cincinnati, College of Pharmacy and a Bachelors in Pharmacy from M.S. University in India.

Sudhir Sahasrabudhe

CSO/CEO JSK Therapeutics

Angus Sinclair

Vice President Oncology IGM Biosciences

Abhit Singh

Chief Regulatory Officer Intrommune Therapeutics

Topic: Implementation of innovative approaches to achieve Proof-of-Concept results in record time in Early Phase Clinical Trials?
With close to two decades of professional experience in Healthcare and Biotechnology, Dr. Singh is evidenced to be a consummate professional. Dr. Singh received his MD on a full-ride scholarship from Govt’ Medical College, India — and a Master’s in Health Administration with MBA Finance Electives from the University of Southern California, Los Angeles. Besides previous experience as a practising Primary Care Physician, Dr. Singh served as the Chief Medical Officer for Los Angeles based Clear Protocol, Inc., an Augmented Reality Google- Glass Medical Technology Startup deploying CMS mandated checklists in Medicine and Surgery.  His repertoire of other roles include Chief Medical Advisor for WeHeal Foundation presently– besides Medical Advisory Board for Exosomics Inc, Medical Advisory Board for PrognosDx Health, Senior Corporate Ambassador for Relamatrix Group Inc. etc. 
His areas of expertise are in Molecule Discovery Lifecycle (including Clinical Development), Regulatory Interactions, Stewardship of Clinical Science Teams, Pharmacovigilance, Molecular Diagnostics, Liquid Onco-Biopsy, Product Development Phase Protocol Review, and Medical Affairs Strategy & Logistics. For Healthcare, his specialties include, but are not limited to: Providers, Payors, Pharma Engagement, Continuum of Care Strategy & Operations, Patient Experience, Brand Architecture, Health Information Technology, and Corporate Consulting.

Erica Stone

VP, Oncology Gigagen Inc

Charles Theuer

President & CEO TRACON Pharmaceuticals

Dr. Theuer has served as President, Chief Executive Officer and a member of the board of directors of TRACON Pharmaceuticals since July 2006. From 2004 to 2006, Dr. Theuer was the Chief Medical Officer and Vice President of Clinical Development at TargeGen, Inc., a biotechnology company, where he led the development of small molecule kinase inhibitors in oncology, ophthalmology and cardiovascular disease. Prior to joining TargeGen, Inc., Dr. Theuer was Director of Clinical Oncology at Pfizer, Inc., a pharmaceutical corporation, from 2003 to 2004. At Pfizer, Dr. Theuer led the clinical development of Sutent® in kidney cancer; Sutent® was approved by the U.S. Food and Drug Administration in 2006 for the treatment of advanced kidney cancer. Dr. Theuer has also held senior positions at IDEC Pharmaceuticals Corp. from 2002 to 2003 and at the National Cancer Institute from 1991 to 1993. In addition, he has held academic positions at the University of California, Irvine, where he was Assistant Professor in the Division of Surgical Oncology and Department of Medicine. Dr. Theuer received a B.S. from the Massachusetts Institute of Technology, an M.D. from the University of California, San Francisco, and a Ph.D. from the University of California, Irvine. He completed a general surgery residency program at Harbor-UCLA Medical Center and was board certified in general surgery in 1997.  Dr. Theuer’s previous research involved immunotoxin and cancer vaccine development, translational work in cancer patients, and gastrointestinal cancer epidemiology.

Michael Weis

Principal Modeler Rosa & Co

Adam Wolfberg

Chief Medical Officer Current Health

Forjan Zamanian

Senior Director Regulatory Affairs Jazz Pharmaceuticals

Christopher Varner

Project Manager IQVIA Virtual Trial Solutions

See the Full 2021 Facilitator Line-up

Download the brochure for more details including the full roundtable descriptions

Download Brochure

Reasons to Attend the Virtual Strategy Meeting

Fully Interactive Virtual Conference

We’re all bored of the same webinar format by now. Instead, join intimate groups of like-minded professionals and discuss the topics that really matter to you

Personalised and Easy to Join Agenda

Pick the roundtable discussions that you want to be part of. Simply choose your sessions and we will send you the direct links and calendar reminder to join

Senior Decision Makers

All our roundtable discussions are aimed at director level and above. Discover how your peers are tackling the industries biggest challenges and have your thoughts heard

Private and Intimate Discussions

Each sessions is read by an industry expert and the roundtables are limited to ensure you have fruitful and genuine conversations with your colleagues

Agenda

See Which Topics Are Discussed at the Online Strategy Meeting

08:45 PDT

Roundtable Tracks

Risk Based Monitoring: What are the threats, impacts and implications of risk-based monitoring during a global crisis? Patient Recruitment / Patient Centricity & Virtual Trials: The impact of COVID-19 on patient recruitment: Clinical Outsourcing: Relationship management in the era of COVID-19: establishing best practices, new metrics, and effective communication during a crisis A.I & Disruptive Technology: Harnessing the future of Artificial Intelligence (AI) to transform clinical trials Emerging Biopharma: How can patients be informed on clinical trials recruiting for their disease? Clinical Data/RWE: Tools to enable data capture through electronic means and increased virtualization such as electronic consent, eCOA, telehealth and medical wearables Biomarker Discovery: Biomarkers in combination cancer immunotherapy Precision Medicine: Discover strategies to enhance integration of clinical genomics & precision medicine for cancer therapy Immuno-oncology: Strategies to Improve Antitumor Efficacy of Genetically Engineered T Cells Research & Development: Strategies for Conducting Pediatric Studies in support of Clinical Development Programs

10:00 PDT

Decentralized/Hybrid Clinical Trials in Oncology: Exploring Currents Challenges and Implementing Best Practices Archana Sah — Vice President, Head of Clinical Development Operations, Tizona Therapeutics, Inc and Oncology Board Chair, Society for Clinical Research Sites

10:45 PDT

Roundtable Tracks

Risk Based Monitoring: Mitigating risks around data quality issues through various forms of centralized monitoring Patient Recruitment / Patient Centricity & Virtual Trials: Predicting and Improving Patient Enrollment through Evidence, Data, New Tech and Creative Engagement – Reify Health Clinical Outsourcing: Internal delivery VS. external: What studies should now be kept in house VS what should be outsourced using realistic parameters A.I & Disruptive Technology: How can technology help clinical trials streamline imaging workflows to complete study goals? Emerging Biopharma: Predict, identify and respond to sporadic disruptions in the COVID era – COUCH Clinical Data/RWE: Prioritizing Patient Experience in Oncology Trials: Electronic Patient-Reported Outcome Data Collection – yprime Biomarker Discovery: Designing a biomarker strategy to deliver systematic monitoring of immune modulation that informs tumour response Precision Medicine: Assessing the role of screening, early detection, and management of cancer patients Immuno-oncology: Accelerating clinical development of next- generation immune therapies: Strategic and operational considerations for biotech – IQVIA Biotech Research & Development: CRS Remote Monitoring in Immunotherapy: Enabling Outpatient Treatment & Digital Biomarker Development – Current Health

12:00 PDT

Keynote Delivered by ARENSIA Claudia Hesselmann, PhD — Co-founder & CEO, ARENSIA Tatiana Eidus — Director Corporate Development North America, ARENSIA

12:45 PDT

Roundtable Tracks

Risk Based Monitoring: Exploring the future of remote monitoring and telemedicine through COVID-19 and beyond Patient Recruitment / Patient Centricity & Virtual Trials: Getting back on track: How can approved trials on hold resume whilst adapting to global changes Clinical Outsourcing: What is the current state and future vision of vendor qualification and oversight? A.I & Disruptive Technology: What are the examples of costs and time savings using AI/machine intelligence? Emerging Biopharma: Overcoming challenges in clinical operations and site management: Innovative approaches to ensure compliance and improve quality Clinical Data/RWE: Emerging trends in the expanded use of RWE across the life sciences industry. Where is the industry going? Biomarker Discovery: Utilization of AI, data science and pathology to enhance biomarker discovery Precision Medicine: Clinical and regulatory strategies for expediting drug development process in oncology to treat rare and ultra-rare diseases Immuno-oncology: Targeting Tumor-Reactive T Cells for Adoptive Immunotherapy in Humans Research & Development: Novel anti-cancer strategy: latest development of treatments targeting metabolic differences

14:00 PDT

Roundtable Tracks

Risk Based Monitoring: Identify challenges when defining appropriate metrics to measure the impact of risk-based monitoring Patient Recruitment / Patient Centricity & Virtual Trials: Improving clinical study planning and modelling through patient-centric initiatives: Virtual trials, online patient recruitment, ePRO, social media, mHealth Clinical Outsourcing: Utilizing the procurement team for cost savings, improved budgeting, better aligned technology, and stronger partner relationships A.I & Disruptive Technology: How can we bring disruptive technology innovations across all steps of clinical fields? Emerging Biopharma: Understanding your protocol and its burden on your patients, clin ops teams, sites and caregivers Clinical Data/RWE: How are mobile technologies, AI, and machine learning being used to generate RWE? Biomarker Discovery: New Methodologies Behind Predicative Biomarkers to Improve Rates and Ratio Of End Result Precision Medicine: Integrating clinical genomics and precision medicine for cancer therapy Immuno-oncology: The development of cellular therapies continues to be an ongoing area of research due to limitations/ barriers observed with previous therapeutic approaches for liquid and solid tumors Research & Development: Implementation of translational research and imaging sciences in clinical trials

Join 150+ Senior Directors and Vice Presidents

Download the full Strategy Meeting brochure for more details including how the register your place

Download Brochure

Here To Help

Want to know more? Interested in sponsoring the event? Need help registering you team? Just get in touch and a member of the team will be happy to help.

Quick Links

Want to find out more?

Find out more details about our Strategy Meetings and other news and events.

Europe

USA East

USA West

Webinars

Dinners & Spotlights

R&D

Clinical Trials Online

Online Events

ONLINE

CLINICAL OPERATIONS & ONCOLOGY

Strategy Meeting Online West Coast 2021

Insights without leaving your home

What makes our strategy meetings unique?

Roundtable Discussions

Unrivalled Networking

Personalised Agenda

Totally Virtual Format

Industry Researched Topics

Senior Decision Makers

Facilitator Faculty

Andreas Bader

Ash Rishi

Reid Bissonnette

Gajanan Bhat

Veronica Cuevas Brenner

Elena Brin

Michael A. Damore

Tatiana Eidus

Celeste A. Elash

Erin Filbert

Erin Finot

Rachel Gaskell

Majid Ghoddusi

Ari Gnanasakthy

Claudia Hesselmann, PhD

Jack Hiro

Niharika Kamat

Tahira Khan

Andy Kinley

Tanya Russell Kirkpatrick

Elina Lavit

John Makowski

Prasun Mishra

Donna M. Mongiello

Ralph Passarella

Jonathan Rabinowitz

Ash Rishi

Kevin Ryan

Archana Sah

Sudhir Sahasrabudhe

Angus Sinclair

Abhit Singh

Erica Stone

Charles Theuer

Michael Weis

Adam Wolfberg

Forjan Zamanian

Christopher Varner

See the Full 2021 Facilitator Line-up

Reasons to Attend the Virtual Strategy Meeting

Fully Interactive Virtual Conference

Personalised and Easy to Join Agenda

Senior Decision Makers

Private and Intimate Discussions

See Which Topics Are Discussed at the Online Strategy Meeting

Opening Panel

Roundtable

Roundtable Tracks

Industry Presentation

Roundtable

Roundtable Tracks

Keynote Session

Roundtable

Roundtable Tracks

Roundtable

Roundtable Tracks

End of Day

Join 150+ Senior Directors and Vice Presidents

Our 2021 Co-hosts

Here To Help